Shareholder Investigation: Is Bluebird Bio Delivering Fair Value to Its Public Shareholders? – Ademi LLP Explores Potential Undervaluation

Ademi LLP Investigates Bluebird Corporation for Alleged Fiduciary Duty Breaches and Violations of Law

MILWAUKEE, WISCONSIN – In a recent development that has raised concerns among investors, Ademi LLP, a leading securities law firm, has initiated an investigation into Bluebird Corporation (Nasdaq: BLUE) regarding potential breaches of fiduciary duty and other legal violations. The investigation focuses on Bluebird’s transaction with Carlyle Group and SK Capital, in which Bluebird stockholders are set to receive $3.00 per share in cash and a contingent value right.

Background on the Transaction

The transaction in question occurred when Carlyle Group and SK Capital Partners made a tender offer to acquire all outstanding shares of Bluebird Corporation for $3.00 per share in cash, and a contingent value right (CVR) that could potentially pay additional amounts if certain regulatory approvals are obtained. The offer represents a premium of approximately 32% based on the 30-day volume-weighted average price before the announcement.

The Allegations

Ademi LLP is examining whether the Bluebird Corporation’s Board of Directors breached their fiduciary duties to the company and its stockholders by agreeing to the transaction. Fiduciary duty refers to the legal obligation of a Board of Directors to act in the best interests of their company and its shareholders. The law firm is also investigating whether any securities laws were violated in the process.

Implications for Bluebird Corporation Shareholders

For Bluebird Corporation shareholders, the outcome of this investigation could potentially result in significant financial gains. If it is found that the Board of Directors breached their fiduciary duties, shareholders may be entitled to damages. Additionally, if securities laws were violated, shareholders may be able to recover damages under the securities laws.

Global Impact of the Investigation

Beyond the immediate impact on Bluebird Corporation and its shareholders, this investigation could set a precedent for future corporate transactions. If it is determined that the Bluebird Corporation Board of Directors breached their fiduciary duties, it may encourage greater scrutiny of similar transactions in the future. This could lead to increased transparency and potentially higher values for shareholders in similar situations.

  • Bluebird Corporation shareholders could be entitled to damages if fiduciary duties were breached.
  • Securities laws may have been violated in the transaction.
  • The outcome of the investigation could set a precedent for future corporate transactions.

Contact Ademi LLP for More Information

If you are a Bluebird Corporation shareholder and believe that your rights may have been violated, you may contact Ademi LLP for a free and confidential consultation. You can reach the firm by email at [email protected] or by calling toll-free at 866-264-3995. There is no cost or obligation to you.

Conclusion

The investigation into Bluebird Corporation by Ademi LLP raises important questions about the fiduciary duties of corporate Boards of Directors and the potential legal implications of their actions. The outcome of this investigation could have far-reaching consequences for the company, its shareholders, and the business world as a whole. For more information or to discuss your potential claims, contact Ademi LLP today.

Leave a Reply